Pathogenesis and Syndrome Differentiation and Treatment of Dyslipidemia-Related Residual Cardiovascular Risk:from the Perspective of Shaoyang (少阳) Pivot Dysfunction
10.13288/j.11-2166/r.2026.22.008
- VernacularTitle:从少阳枢机不利探析血脂异常相关心血管残余风险的病机与辨治
- Author:
Siqi LI
1
;
Hua QU
2
;
Lingli ZHAO
2
;
Min LI
1
;
Dazhuo SHI
2
Author Information
1. Graduate School, Beijing University of Chinese Medicine, Beijing, 100029
2. Xiyuan Hospital, China Academy of Chinese Medical Sciences
- Publication Type:Journal Article
- Keywords:
shaoyang (少阳) pivot;
dyslipidemia;
residual cardiovascular risk;
atherosclerosis;
lipid turbidity
- From:
Journal of Traditional Chinese Medicine
2026;67(22):2408-2412
- CountryChina
- Language:Chinese
-
Abstract:
Dysfunction of the shaoyang (少阳) pivot is the initiating pathomechanism underlying the development and progression of dyslipidemia-related residual cardiovascular risk. It may disturb the coursing and discharging functions of the liver and gallbladder, the transportation and transformation functions of the spleen and stomach, and the qi transformation of sanjiao (三焦), thereby affecting the downward movement of qi in the bowels and contributing to the formation and transport of lipid turbidity, as well as the pathological progression of phlegm, stasis, turbidity, and toxins. The predominant pathomechanisms may vary across different stages of the condition. For shaoyang qi constraint with dysfunction of the pivot, modified Chaihu Shugan Powder (柴胡疏肝散) is prescribed to regulate the liver and promote gallbladder function, and restore the free flow of the pivot mechanism. For spleen failing to transport and transform with endogenous accumulation of lipid turbidity, modified Shenling Baizhu Powder (参苓白术散) combined with Erchen Decoction (二陈汤) is prescribed to fortify the spleen, resolve turbidity, raise the clear, and descend the turbid. For impaired bowel conduction with lipid turbidity entering the bloods, modified Dachaihu Decoction (大柴胡汤) combined with Zengye Chengqi Decoction (增液承气汤) is prescribed to promote bowel movement and eliminate turbidity, while regulating both shaoyang and yangming (阳明). For lipid turbidity entering the collaterals with intermingled phlegm and stasis, modified Haoqin Qingdan Decoction (蒿芩清胆汤) combined with Xuefu Zhuyu Decoction (血府逐瘀汤) is prescribed to invigorate blood and unblock the collaterals, resolve phlegm and dispel stasis. For collateral damage caused by turbid toxins with unstable plaques, modified Wendan Decoction (温胆汤) combined with Qingying Decoction (清营汤) is prescribed to eliminate toxins, stabilize plaques, unblock the collaterals, and prevent disease progression.